The role of T cell trafficking in CTLA-4 blockade-induced gut immunopathology
Abstract Background Immune checkpoint inhibitor (ICPI) can augment the anti-tumour response by blocking negative immunoregulators with monoclonal antibodies. The anti-cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) antibody is the first ICPI which has shown remarkable benefits in the clinical t...
Gorde:
| Egile Nagusiak: | , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMC
2020-03-01
|
| Saila: | BMC Biology |
| Gaiak: | |
| Sarrera elektronikoa: | http://link.springer.com/article/10.1186/s12915-020-00765-9 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|